Functional analyses of BRE knockdown or overexpression in four ESCC cells and mechanistic assays were carried out, followed by in vivo analysis using a mouse xenograft model to analyze the expression pattern of BRE in ESCC and determine its role in ESCC progression. The gene discussed is BABAM2; the disease is esophageal squamous cell carcinoma.